Gencell Ltd
GNCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,549 | $4,864 | $7,403 | $5,761 |
| % Growth | 96.3% | -34.3% | 28.5% | – |
| Cost of Goods Sold | $10,496 | $10,034 | $9,599 | $10,134 |
| Gross Profit | -$947 | -$5,170 | -$2,531 | -$4,373 |
| % Margin | -9.9% | -106.3% | -34.2% | -75.9% |
| R&D Expenses | $8,446 | $13,208 | $7,501 | $5,107 |
| G&A Expenses | $1,593 | $7,056 | $6,111 | $6,973 |
| SG&A Expenses | $3,306 | $11,217 | $10,914 | $11,753 |
| Sales & Mktg Exp. | $1,713 | $4,161 | $5,320 | $4,780 |
| Other Operating Expenses | $6,499 | $0 | $0 | -$4 |
| Operating Expenses | $18,251 | $24,425 | $18,415 | $16,856 |
| Operating Income | -$19,198 | -$29,595 | -$22,445 | -$20,422 |
| % Margin | -201% | -608.4% | -303.2% | -354.5% |
| Other Income/Exp. Net | -$161 | $1,350 | -$14,040 | -$603 |
| Pre-Tax Income | -$19,359 | -$28,245 | -$36,485 | -$21,025 |
| Tax Expense | $75 | $57 | $191 | $65 |
| Net Income | -$19,434 | -$28,302 | -$36,676 | -$21,090 |
| % Margin | -203.5% | -581.9% | -495.4% | -366.1% |
| EPS | -0.18 | -0.26 | -0.34 | -0.22 |
| % Growth | 30.8% | 23.5% | -54.5% | – |
| EPS Diluted | -0.18 | -0.26 | -0.34 | -0.22 |
| Weighted Avg Shares Out | 108,993 | 107,657 | 107,509 | 95,864 |
| Weighted Avg Shares Out Dil | 108,993 | 107,657 | 107,509 | 95,864 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,161 | $3,265 | $2,392 | $350 |
| Interest Expense | $241 | $79 | $119 | $870 |
| Depreciation & Amortization | $1,600 | $1,751 | $1,228 | $1,385 |
| EBITDA | -$17,613 | -$26,505 | -$33,488 | -$19,343 |
| % Margin | -184.4% | -544.9% | -452.4% | -335.8% |